Medtronic's CoreValve gets US nod in bigger patient pool
This article was originally published in Clinica
Executive Summary
Medtronic’s CoreValve can now be used in more US patients than any other transcathether aortic valve, the company claims – after the US FDA expanded approval to include patients at high risk for surgery.